Bausch Health Companies Inc.
BHC.TO
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 92.23% | 81.52% | -153.23% | -27.45% | -163.11% |
| Total Depreciation and Amortization | 0.24% | -0.46% | -4.59% | -7.05% | -9.33% |
| Total Amortization of Deferred Charges | 55.68% | 117.19% | 129.31% | -5.21% | -11.11% |
| Total Other Non-Cash Items | -72.83% | -84.16% | 160.89% | 165.38% | 153.38% |
| Change in Net Operating Assets | 101.20% | 89.17% | 42.16% | -17.55% | -46.97% |
| Cash from Operations | 54.75% | 24.08% | 395.09% | 313.11% | 241.76% |
| Capital Expenditure | -56.74% | -79.78% | -53.85% | -14.16% | 1.38% |
| Sale of Property, Plant, and Equipment | 40.00% | -30.00% | 0.00% | 20.00% | 0.00% |
| Cash Acquisitions | 92.80% | 97.52% | -2,346.05% | -2,346.05% | -4,100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 126.67% | -14.29% | -12.50% | -5.71% | 0.00% |
| Cash from Investing | 78.83% | 81.15% | -637.04% | -558.46% | -607.92% |
| Total Debt Issued | -79.91% | -91.40% | 208.03% | -46.53% | -51.86% |
| Total Debt Repaid | 14.62% | 41.19% | -31.11% | 76.16% | 78.21% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -8.33% | 0.00% | -58.82% | -44.44% | 22.58% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 47.56% | 17.39% | -14.67% | -115.29% | -114.46% |
| Cash from Financing | -158.85% | -180.75% | 269.51% | 217.80% | 411.18% |
| Foreign Exchange rate Adjustments | -500.00% | -14.29% | -250.00% | 77.78% | 139.13% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -35.58% | -110.60% | 102.71% | 111.61% | 124.28% |
